Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Tang

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Cell|April 23, 2022
Circular RNA vaccines against SARS-CoV-2 and emerging variantsLiang Qu, Zongyi Yi, Yong Shen, et al.
Cell|May 14, 2022
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2Kun Xu, Ping Gao, Sheng Liu, et al.
Signal Transduction and Targeted Therapy|February 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariantsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|November 20, 2024
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variantsHong Lei, Weiqi Hong, Jingyun Yang, et al.
Nature Communications|September 17, 2022
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantCai He, Jingyun Yang, Weiqi Hong, et al.
Chembiochem : a European Journal of Chemical Biology|March 21, 2023
PSL Chemical Biology Symposia Third Edition: A Branch of Science in its Explosive PhaseLeeroy Baron, Justine Hadjerci, Leishemba Thoidingjam, et al.
The Journal of Clinical Investigation|September 17, 2024
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like proteaseWenyan Ren, Weiqi Hong, Jingyun Yang, et al.
Nature|September 25, 2024
Designed endocytosis-inducing proteins degrade targets and amplify signalsBuwei Huang, Mohamad Abedi, Green Ahn, et al.
Nature Biomedical Engineering|September 22, 2025
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variantWeiqi Hong, Ping Cheng, Jingyun Yang, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Cell|April 23, 2022
Circular RNA vaccines against SARS-CoV-2 and emerging variantsLiang Qu, Zongyi Yi, Yong Shen, et al.
Cell|May 14, 2022
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2Kun Xu, Ping Gao, Sheng Liu, et al.
Signal Transduction and Targeted Therapy|February 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariantsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|November 20, 2024
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variantsHong Lei, Weiqi Hong, Jingyun Yang, et al.
Nature Communications|September 17, 2022
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantCai He, Jingyun Yang, Weiqi Hong, et al.
Chembiochem : a European Journal of Chemical Biology|March 21, 2023
PSL Chemical Biology Symposia Third Edition: A Branch of Science in its Explosive PhaseLeeroy Baron, Justine Hadjerci, Leishemba Thoidingjam, et al.
The Journal of Clinical Investigation|September 17, 2024
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like proteaseWenyan Ren, Weiqi Hong, Jingyun Yang, et al.
Nature|September 25, 2024
Designed endocytosis-inducing proteins degrade targets and amplify signalsBuwei Huang, Mohamad Abedi, Green Ahn, et al.
Nature Biomedical Engineering|September 22, 2025
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variantWeiqi Hong, Ping Cheng, Jingyun Yang, et al.
Pageof 17